PROX1 and breast carcinoma: In contrast to the aforementioned study, Agarwal et al. established via examination of the expression of three lymphatic-specific markers (D240, podoplanin, and PROX1) in breast cancer tissues that, unlike angiogenesis, breast cancer development and progression were not associated with lymphangiogenesis [31].